EUVIMEDEUVIMED entdecken
Klinische Studie (Phase IV)Randomisierte kontrollierte Studie

Vedolizumab for the Treatment of Chronic Pouchitis

Simon Travis, Mark S Silverberg, Silvio Danese, Paolo Gionchetti, Mark Löwenberg, Vipul Jairath, Brian G Feagan, Brian Bressler, Marc Ferrante, Ailsa Hart, Dirk Lindner, Armella Escher und 3 weitere

New England Journal of Medicine · 30.03.2023 · 388 (13) · 1191-1200

DOI: 10.1056/nejmoa2208450 ↗

Kurz gefasst

Klinische Studie (Phase IV) in der Zeitschrift New England Journal of Medicine, erschienen am 30.03.2023. Verfasst von Simon Travis und 14 weiteren Autor:innen. Beteiligte Einrichtung: From the Translational Gastroenterology Unit and Kennedy Institute, National Institute for Health and Care Research Oxford Biomedical Research Centre…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Pouchitis, Gastrointestinal Agents, Proctocolectomy, Restorative. Die Arbeit wurde bisher 121-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Takeda.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativePouchitisGastrointestinal AgentsProctocolectomy, RestorativeAdultHumansAntibodies, Monoclonal, HumanizedCiprofloxacinChronic DiseaseDouble-Blind MethodAnti-Bacterial AgentsAdministration, IntravenousDrug Therapy, Combination

Substanzen

Antibodies, Monoclonal, HumanizedCiprofloxacinvedolizumabGastrointestinal AgentsAnti-Bacterial Agents

Autor:innen und Institutionen

  • From the Translational Gastroenterology Unit and Kennedy Institute, National Institute for Health and Care Research Oxford Biomedical Research Centre, University of Oxford, Oxford (S.T.), and the Inflammatory Bowel Dise…

Förderung

  • Takeda

Zitieren

APA

Travis, S., Silverberg, M. S., Danese, S., Gionchetti, P., Löwenberg, M., Jairath, V., Feagan, B. G., Bressler, B., Ferrante, M., Hart, A., Lindner, D., Escher, A., Jones, S., Shen, B., & EARNEST Study Group (2023). Vedolizumab for the Treatment of Chronic Pouchitis. New England Journal of Medicine, 388(13), 1191-1200. https://doi.org/10.1056/nejmoa2208450

Vancouver

Travis S, Silverberg MS, Danese S, Gionchetti P, Löwenberg M, Jairath V, et al. Vedolizumab for the Treatment of Chronic Pouchitis. New England Journal of Medicine. 2023;388(13):1191-1200. doi:10.1056/nejmoa2208450

BibTeX
@article{Travis2023,
  author = {Travis, Simon and Silverberg, Mark S and Danese, Silvio and Gionchetti, Paolo and Löwenberg, Mark and Jairath, Vipul and Feagan, Brian G and Bressler, Brian and Ferrante, Marc and Hart, Ailsa and Lindner, Dirk and Escher, Armella and Jones, Stephen and Shen, Bo and EARNEST Study Group, EARNEST Study Group},
  title = {Vedolizumab for the Treatment of Chronic Pouchitis},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {388},
  number = {13},
  pages = {1191--1200},
  doi = {10.1056/nejmoa2208450}
}
Kostenlos starten →